Helicobacter pylori: from the stomach to the heart

Area of Science:

• Cardiovascular Medicine
• Infectious Diseases
• Gastroenterology

Background:

• Extra-gastrointestinal diseases, including coronary heart disease (CHD) and stroke, are increasingly linked to Helicobacter pylori infection.
• CHD is a leading cause of death, and its risk factors do not fully explain its pathogenesis, prompting research into infectious agents.
• H. pylori was identified as a potential contributor to CHD in 1994, leading to numerous studies with conflicting findings.

Purpose of the Study:

• To explore the potential causal role of Helicobacter pylori infection in the development of coronary heart disease.
• To highlight the heterogeneity in existing studies regarding patient selection and disease classification (CHD vs. acute myocardial infarction).
• To emphasize the need for separate investigations into the chronic and acute phases of CHD in relation to H. pylori.

Main Methods:

• Review of existing epidemiological and pathogenic studies linking H. pylori infection to coronary heart disease.
• Analysis of proposed mechanisms by which H. pylori may contribute to cardiovascular pathology.
• Identification of research gaps and recommendations for future study designs.

Main Results:

• H. pylori infection is associated with mechanisms relevant to cardiovascular disease, including platelet aggregation and procoagulant activity.
• The bacterium may promote atherosclerosis via elevated homocysteine levels (due to reduced folic acid/cobalamin) or autoimmune processes.
• Existing studies exhibit significant heterogeneity, hindering definitive conclusions about a causal relationship.

Conclusions:

• Helicobacter pylori infection presents plausible mechanisms for contributing to coronary heart disease development.
• Further prospective cohort studies and interventional trials are essential.
• Separate, focused research on chronic and acute CHD phases is crucial for establishing a definitive causal link with H. pylori.